Literature DB >> 6698607

Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.

L D Hazlett, R S Berk.   

Abstract

The ocular histopathological response of C3-depleted and normal DBA/2J mice was compared after corneal scarification and experimental infection with topically applied Pseudomonas aeruginosa. Normal, non-C3-depleted mice were capable of mounting a vigorous polymorphonuclear leukocyte response at 24 h after bacterial challenge and eventually restored corneal clarity. In contrast, C3-depleted animals responded at 24 h to the ocular bacterial challenge with a decreased number of polymorphonuclear leukocytes migrating into the cornea. Additionally, the eyes of C3-depleted mice exhibited persistence of bacteria, cataract of the ocular lens, and loss of vision.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698607      PMCID: PMC264248          DOI: 10.1128/iai.43.3.783-790.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Embedding in epoxy resins for ultrathin sectioning in electron microscopy.

Authors:  K C RICHARDSON; L JARETT; E H FINKE
Journal:  Stain Technol       Date:  1960-11

2.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

3.  Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.

Authors:  E J Ziegler; H Douglas
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

4.  Alternate pathway activation of complement in a Proteus mirabilis ulceration of the cornea.

Authors:  B J Mondino; S I Brown; B S Rabin; J Bruno
Journal:  Arch Ophthalmol       Date:  1978-09

5.  Role of complement in murine corneal infection caused by Pseudomonas aeruginosa.

Authors:  R P Cleveland; L D Hazlett; M A Leon; R S Berk
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-02       Impact factor: 4.799

6.  Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa.

Authors:  K W Beisel; L D Hazlett; R S Berk
Journal:  Proc Soc Exp Biol Med       Date:  1983-04

7.  Genetic control of the murine corneal response to Pseudomonas aeruginosa.

Authors:  R S Berk; M A Leon; L D Hazlett
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

8.  Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

Authors:  D B Budzko; M C Pizzimenti; F Kierszenbaum
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

9.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  10 in total

1.  The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.

Authors:  Aaron B Sullivan; K P Connie Tam; Matteo M E Metruccio; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  A novel murine model for contact lens wear reveals clandestine IL-1R dependent corneal parainflammation and susceptibility to microbial keratitis upon inoculation with Pseudomonas aeruginosa.

Authors:  Matteo M E Metruccio; Stephanie J Wan; Hart Horneman; Abby R Kroken; Aaron B Sullivan; Tan N Truong; James J Mun; Connie K P Tam; Robin Frith; Laurence Welsh; Melanie D George; Carol A Morris; David J Evans; Suzanne M J Fleiszig
Journal:  Ocul Surf       Date:  2018-11-12       Impact factor: 5.033

3.  Microbiological diagnosis of suppurative keratitis in Bangladesh.

Authors:  G Williams; F Billson; R Husain; S A Howlader; N Islam; K McClellan
Journal:  Br J Ophthalmol       Date:  1987-04       Impact factor: 4.638

4.  Inhibition of bacterial adherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aeruginosa corneal infection.

Authors:  T S Zaidi; M J Preston; G B Pier
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

Review 5.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

6.  Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.

Authors:  Tanweer S Zaidi; Tauqeer Zaidi; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

7.  The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.

Authors:  Gregory P Priebe; Charles R Dean; Tanweer Zaidi; Gloria J Meluleni; Fadie T Coleman; Yamara S Coutinho; Michael J Noto; Teresa A Urban; Gerald B Pier; Joanna B Goldberg
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 8.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

Review 9.  The role of complement in ocular pathology.

Authors:  Nalini S Bora; Purushottam Jha; Puran S Bora
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

10.  Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa.

Authors:  Michael Osthoff; Karl D Brown; David C M Kong; Mark Daniell; Damon P Eisen
Journal:  Mol Vis       Date:  2014-01-06       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.